Double systemic cytokine release syndrome following sequential infusion of anti-CD22 and anti-CD19 chimeric antigen receptor T cells after autologous hematopoietic stem cell transplantation for a central diffuse large B-cell lymphoma patient: A case report and literature review

BACKGROUND: Chimeric Antigen Receptor T cell(CAR T-cell) therapy has been a great success in relapsed/refractory acute B lymphoblastic leukemia and B-cell lymphoma. At the same time, there are also related adverse reactions, especially cytokine release syndrome(CRS) and immune effector cell associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jing, Xiao, Yao, Wu, Xue Q., Xiao, Qiong Z., Feng, Chun, Gao, Kai B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927007/
https://www.ncbi.nlm.nih.gov/pubmed/36798130
http://dx.doi.org/10.3389/fimmu.2023.1098815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927007/
https://www.ncbi.nlm.nih.gov/pubmed/36798130
http://dx.doi.org/10.3389/fimmu.2023.1098815

Ejemplares similares